Stockscreener 앱 받기
88.07
2.18%
-1.96
Boston Scientific Corp 주식(BSX)의 최신 뉴스
UnitedHealth Stock Slips Amid Medicare Investigation; Boston Scientific to Acquire Penumbra for $14.5B - Intellectia AI
Penumbra Shares Soar Pre-MarketWhat Is The Boston Scientific Agreement? - Menafn
Is Boston Scientific Corporation (NYSE:BSX) Worth US$88.1 Based On Its Intrinsic Value? - Yahoo Finance
Boston Scientific (BSX) Expands Urology Portfolio with Valencia Deal, Analysts Emphasize Organic Growth - Insider Monkey
Halper Sadeh LLC Encourages PEN, CVGW, AVO Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
A big acquisition decades ago almost broke Boston Scientific. Its CEO says this time is different. - Star Tribune
Med tech company Boston Scientific readies for new Austin offices - MSN
RTW Biotech Opp.Boston Scientific to acquire Penumbra - Research Tree
Boston Scientific (BSX) stock falls again as traders digest $14.5 billion Penumbra buy - TechStock²
Penumbra Inc. to be Sold to Boston Scientific for $374 per Share - Intellectia AI
Boston Scientific to buy Penumbra in $14.5 billion deal - AOL.com
This is Why Wall Street Firms are Bullish on Boston Scientific Corporation (BSX) - Finviz
Truist Securities reiterates Buy rating on Boston Scientific stock - Investing.com
Boston Scientific looks to nearly double size of Minnesota facility - MassDevice
Boston Scientific (BSX): Oppenheimer Adjusts Price Target, Maint - GuruFocus
Down 6.3% in 4 Weeks, Here's Why Boston Scientific (BSX) Looks Ripe for a Turnaround - Yahoo Finance
Boston Scientific (NYSE:BSX) Price Target Lowered to $100.00 at Oppenheimer - MarketBeat
Oppenheimer Adjusts Price Target on Boston Scientific to $100 From $125, Maintains Outperform Rating - marketscreener.com
Leerink Partners downgrades Penumbra stock following Boston Scientific deal - Investing.com
RTW Biotech Opportunities Portfolio Company Penumbra To Be Acquired By Boston Scientific - DirectorsTalk Interviews
Boston Scientific to acquire Penumbra for $14.5 billion - Investing.com
Truist Securities downgrades Penumbra stock to Hold following Boston Scientific acquisition - Investing.com
Boston Scientific Target of Unusually High Options Trading (NYSE:BSX) - MarketBeat
Boston Scientific Buys Heart Device Maker Penumbra For $14.5 Billion - Baystreet.ca
Boston Scientific (BSX) stock drops after $14.5B Penumbra deal; FDA nod and earnings date ahead - TechStock²
Boston Scientific to acquire Penumbra for portfolio of vascular treatments - MLex
Boston Sci swings for the fences with $14.5B Penumbra buy - BioWorld MedTech
One of Alameda's largest companies agrees to be acquired for $14.5 billion - The Business Journals
The Beat: Boston Sci expanding in Maple Grove, TurnSignl demand spikes with ICE - The Business Journals
Why Boston Scientific (BSX) Stock Is Down Today - Finviz
Boston Scientific to acquire California manufacturer for $14.5B - Worcester Business Journal
Boston Scientific (BSX) Plans to Acquire Penumbra for $374 Per S - GuruFocus
Boston Scientific stock holds Buy rating at Needham after Penumbra acquisition - Investing.com
JPM26: Boston Scientific acquires Penumbra in $14.5bn deal - Yahoo Finance
Boston Scientific (NYSE:BSX) Shares Gap DownShould You Sell? - MarketBeat
Boston Scientific to acquire Penumbra in $14.5B deal - Proactive financial news
Boston Scientific beefs up heart device portfolio with $14.5 billion Penumbra deal - Reuters
Boston Scientific pays $14.5B for California medical device company - The Business Journals
Boston Scientific Corp (BSX) Shares Down 4.66% on Jan 15 - GuruFocus
Boston Scientific stock rises as Stifel praises Penumbra acquisition - Investing.com
Morgan Stanley sees Boston Scientific stock as undervalued after Penumbra deal - Investing.com
Boston Scientific beefs up heart device portfolio with $14.5 billion Penumbra deal By Reuters - Investing.com
Boston Scientific (BSX) Announces Acquisition of Penumbra - GuruFocus
Boston Scientific (BSX) Shares Drop on Penumbra Acquisition - GuruFocus
Penumbra Shares Are Rising Today — What Is The Boston Scientific Agreement? - Stocktwits
Boston Scientific Agrees to Buy Penumbra in $14.6 Billion Cardiovascular Deal - GuruFocus
Boston Scientific to buy Penumbra for more than $14B - Modern Healthcare News
Boston Scientific to Acquire Penumbra in $14.5 Billion Cash-Stock Deal - marketscreener.com
Boston Scientific To Acquire Penumbra; Stock Soars - Nasdaq
Boston Scientific Buys Device Maker Penumbra for $14.5 Billion - Bloomberg.com
Boston Scientific to Buy Penumbra in Deal Reflecting $14.5 Billion Enterprise Value - marketscreener.com
3 Firms Advise On Boston Scientific's $14.5B Penumbra Deal - Law360
Boston Scientific to acquire Penumbra for $14.5B - MassDevice
Boston Scientific Corporation entered into a definitive agreement to acquire Penumbra, Inc. for $14.8 billion. - marketscreener.com
Penumbra Shares Soar Pre-Market — What Is The Boston Scientific Agreement? - Asianet Newsable
Boston Scientific to buy Penumbra for more than $14 billion - The Boston Globe
Penumbra surges on news of $14.5 billion Boston Scientific buyout, BSX down - Investing.com
Goldman Sachs and Boston Scientific fall premarket; Morgan Stanley, TSMC rise - Investing.com
Boston Scientific beefs up heart device portfolio with US$14.5 billion Penumbra deal - CTV News
Boston Scientific to acquire Penumbra for enterprise value of ~$14.5B (BSX:NYSE) - Seeking Alpha
2.26%
0.36%
자본화:
|
볼륨(24시간):